chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has developed shingles. He had chickenpox as a child, where they didn't vaccinate against it. He has a bad rash on his scalp, at the back of his head, slight ringing ears and aching neck. Doctor said outbreak will probably increase around neck before scabbing over and healing.
3cm patch of erythema with some induration without excoriation, fever, pruritis or any other problem.
Skin Lesion Information has been received from a health professional concerning a 9 year old white female with down's syndrome who on 27-OCT-1997 was vaccinated with a first subcutaneous dose of varicella virus vaccine live (Oka/Merck) (Lot #623556/0709E). Concomitant vaccine administered on the same day included a third intramuscular dose of Hib conj vaccine (OMPC) (MSD) (Lot #624924/1204E) and a third intramuscular dose of hepatitis B vaccine, recomb (Engerix-B) (Lot #2390A2). There was no illness at the time of vaccination. On 09-JAN-2006 the patient experienced multiple lesions on her torso, face and groin, described as possible infected. The patient was treated with cephalexin (Keflex), mupirocin (Bactroban) and symptomatic care. Subsequently the patient recovered. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. Additional information is not expected.
feel weird long not far from where the shot was given; swelling; arm is still pink in a big patch; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue). At the time of the report, MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
HISTAMINE REACTION AFTER DOSE PROVIDED. TURNED RED, STARTED TO SAY THROAT WAS SWELLING. GAVE BENadryl and issue quickly resolved.
Fever, deep chills, shakes, muscle aches over my entire body, even my hair hurts, a slight dry cough. Very extreme fatigue and I am not able to sleep well which is causing me to be really tired. This started as a pain in my arm couple of hours after vaccination and by the next morning all these symptoms  started. These symptoms are causing me to not be able to function. She has no appetite.  I have spoke to our doctor on the phone  Monday evening 02/08/2021,  our doctor said to drink fluids and take ibuprofen and it will probably go away.  My wife is confused.
This spontaneous report as received from a pharmacist, concerning to two patients (unspecified age and gender). On an unspecified date, two patients were vaccinated with ZOSTAVAX, injection. (Unspecified route, dose and lot number). Co-suspect or concomitant therapies were not reported. On an unspecified date, two patients were vaccinated with ZOSTAVAX stored higher than recommended and not supported. No adverse effect reported. Additional information has been requested.
Acute pulmonary embolism 6/3/2021 at 9:24am prescribed eliquis 10mg, potassium 60 meq, magnesium 2g, morphine 4mg
Severe herpes on chin/ 3 spots on chin; severe Cold sores; limited mobility in the injected arm; muscle pain; localized pain; This non-serious case was reported by a physician via call center representative and described the occurrence of herpes zoster in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cold sores.   On 01-SEP-2023, the patient received the 1st dose of Shingrix (unknown arm). In SEP-2023, 2 days after receiving Shingrix, the patient experienced herpes zoster (Verbatim: Severe herpes on chin/ 3 spots on chin), cold sores (Verbatim: severe Cold sores), injected limb mobility decreased (Verbatim: limited mobility in the injected arm), muscle pain (Verbatim: muscle pain) and pain localized (Verbatim: localized pain).  The outcome of the herpes zoster was not resolved and the outcome of the cold sores, injected limb mobility decreased, muscle pain and pain localized were not reported.   It was unknown if the reporter considered the herpes zoster, cold sores, injected limb mobility decreased, muscle pain and pain localized to be related to Shingrix.     It was unknown if the company considered the herpes zoster, cold sores, injected limb mobility decreased, muscle pain and pain localized to be related to Shingrix.   Additional Information: GSK Receipt Date: 07-SEP-2023  The wife of the patient reported that the patient received the first dose of Shingrix and experienced localized pain, muscle pain, and limited mobility in the injected arm. Two days after receiving the vaccine, the patient experienced severe herpes on his chin. There were currently 3 spots on his chin. The day of reporting was the first day a new sore did not appear. The patient had from time to time, experienced cold sores in the past, but this time it was more severe. The reporter gave permission to call back for further details. The patient was also a Medical Doctor.
Sore; This non-serious case was reported by a other health professional via sales rep and described the occurrence of pain in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included autoimmune disorder.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain (Verbatim: Sore). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingrix.     It was unknown if the company considered the pain to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR088328   Additional Information: GSK Receipt Date: 23-JUN-2023 The patient received 1st dose of Shingrix and adverse event was just sore. For the tolerance of the 2nd dose, refer linked case US2023AMR088328, reported by the same reporter for same patient. The reporter did not consent to follow up.; Sender's Comments:  US-GSK-US2023AMR088328:Same reporter
Information has been received from a physician concerning a 25 year old female who on an unspecified date was vaccinated with the first dose of GARDASIL and on 01-AUG-2008 was vaccinated with the second dose of GARDASIL. After receiving her second dose the patient's arm was very sore, when her shirt touches it, it was very painful. The patient sought unspecified medical attention. At the time of the reporting, the patient had not recovered. Additional information has been requested.
starting 4-5hr p/vax fussiness, would not sleep, some vomiting following feedings (denied high pitched cry, fever) inability to comfort;pt slept only 3hr from 5PM 18FEB till 3PM 19FEB;spit up 3x;no sx of dehydration;
rash-12x7cm dull erythematous macular rash (L) deltoid region Given by Dr.
Hives; enlarged lymph node in one armpit; Pain in bone/extremities; Pain in bone/extremities; Joint pain; Upper body pain; Chills; Aches; Shivers; Headache; Fever; Mild elevation in potassium levels; Nausea, queasy; This is a spontaneous report received from contactable reporter(s) (Other HCP and Nurse). Other Case identifier(s): 2022US001981 (Radius).  A 76-year-old female patient received BNT162b2 (BNT162B2), on 05Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 76 years, in arm for covid-19 immunisation; abaloparatide (TYMLOS), from 10Jan2022 (Batch/Lot number: unknown) to 24Apr2022 at 80 ug 4x/day (80 ug, 4x/day (80 mcg, qd)), subcutaneous for osteoporosis. The patient's relevant medical history included: "Allergy: Sulfacetamide powder" (ongoing), notes: allergies to erythromycin, prazosin, clarithromycin, and sulfacetamide powder. Concomitant medication(s) included: VITAMIN D3; VITAMIN B12 NOS; ESTRACE. Past drug history included: Allergy: erythromycin for Drug hypersensitivity, notes: allergies to erythromycin, prazosin, clarithromycin, and sulfacetamide powder.; Allergy: prazosin for Drug hypersensitivity, notes: allergies to erythromycin, prazosin, clarithromycin, and sulfacetamide powder.; Allergy: clarithromycin for Drug hypersensitivity, notes: allergies to erythromycin, prazosin, clarithromycin, and sulfacetamide powder. Vaccination history included: Covid-19 vaccine (Primary immunization series completed but manufacturer unknown.), for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 05Apr2022, outcome "not recovered", described as "Aches"; CHILLS (non-serious) with onset 05Apr2022, outcome "not recovered"; PYREXIA (non-serious) with onset 05Apr2022, outcome "unknown", described as "Fever"; HEADACHE (non-serious) with onset 05Apr2022, outcome "not recovered"; CHILLS (non-serious) with onset 05Apr2022, outcome "not recovered", described as "Shivers"; ARTHRALGIA (non-serious) with onset 06Apr2022, outcome "recovering", described as "Joint pain"; BONE PAIN (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 06Apr2022, outcome "recovering" and all described as "Pain in bone/extremities"; PAIN (non-serious) with onset 06Apr2022, outcome "recovering", described as "Upper body pain"; BLOOD POTASSIUM INCREASED (non-serious) with onset Apr2022, outcome "unknown", described as "Mild elevation in potassium levels"; NAUSEA (non-serious) with onset Apr2022, outcome "recovered", described as "Nausea, queasy"; URTICARIA (non-serious), outcome "not recovered", described as "Hives"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "enlarged lymph node in one armpit". Relevant laboratory tests and procedures are available in the appropriate section. The action taken for abaloparatide was temporarily withdrawn on 24Apr2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever began with low grade, increased to high of 102.2.  Treated with Children's Ibuprofen.   5/23 - Low grade fever in morning, again crept up to around 100 degrees, given Children's Ibuprofen again.  Complained of ear pain and pressure in his ear. 5/24 - Low grade fever in morning.  Around 10am started complaining about ear pain again, got progressively worse and took him to Dr. who diagnosed double ear infection and a "blister" on his eardrum that will likely rupture.  Right ear was worse than left.  More concerned about said "blister" on right eardrum. Gave him numbing drops in both ears and prescribed amoxicillin 2x a day.
Child passed out / lost consciousness temporarily and entire body seized rigid for a moment (less than one minute).  Took approximately fifteen minutes before she was able to consistently maintain consciousness without eye rolling or lolling in and out of semi consciousness.  Unable to maintain continuous conversation.  Face very pale and lips white - about 20-25 minutes before fully regained normal color and the woozy feeling started to subside.  This reaction was worse and consciousness issues were more prolonged than initial reaction to first dose at the same facility on 11/11/2021.  Her body did not seize rigid during the first dose and she was also to recover more quickly / easily from the loss of consciousness without repeated eye rolling / lolling.  First dose was maybe 5-10 minutes to recover.  Benedryl was administered within a few minutes by the pharmacist after the reaction to the first pfizer vaccine.
History of Present Illness:  This is a 65y.o. female  history of ESRD on peritoneal dialysis, status post open MVR and CABG 40 days ago who presents due to chest pain.  Patient had sudden onset chest pressure today.  It is substernal and does not radiate to her back.  It is 7/10 in severity.  She says she thinks she  has had similar chest pain in the past but is never been evaluated for it.  She is on Eliquis.  She reports no shortness of breath or lightheadedness.  She has not yet taken any medications for pain.  She instilled peritoneal dialysis fluid and then came here before draining it.
Pt called pharmacy and stated she received a flu shot and pneumonia shot on the same day a few days ago.  She stated the arm she received the flu shot in was fine but the arm she received the pnuemonia shot in has swelled up from around her elbow all the way up to her shoulder.  She stated it was red and irriated too. She was counseled to contact her PCP in order to be further evaluated.
Extreme vertigo with vision distortion, sweating, shaking, weakness for about 1.5 hours the following morning
Heart palpitations followed by blood pressure dropping then dizziness and actually collapsed. Continued fatigue   Currently on second heart monitor. My life has changed dramatically. I was very healthy and full of energy. Could exercise in am then play one or two rounds of golf a day.  Not now!
This spontaneous report was received from a medical assistant regarding to a 15-month-old male patient. The patient's concurrent conditions, historical conditions, past drugs and concomitant medications were unknown. On 19-DEC-2018 the patient was vaccinated with PROQUAD (dose, frequency, lot#, expiration date were unknown) that had been reconstituted with BOOSTRIX rather than the sterile diluent (product preparation error; wrong product administered) intramuscularly rather than subcutaneously (incorrect route of product administration) for prophylaxis. It was reported that there were no adverse effects. The outcome of product preparation error, no adverse event, incorrect route of product administration and wrong product administered was unknown.
Arm started to itch and sore. Welt like swelling to elbow. Lasted for 4 days then, itch and swelling disappeared. Felt achey at that time and listless. Took Benadryl after speaking with doctor on call.
hives; lot of itching on his body specially inside thighs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (005570).  A 75 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Mar2020 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "hives"; PRURITUS (non-serious), outcome "unknown", described as "lot of itching on his body specially inside thighs".  Additional information: The patient (age more than 75) was hospitalized due to COVID in March2020. He had taken Pfizer vaccines and booster shot. He was having hives and lot of itching on his body specially inside thighs.  The lot number for bnt162b2 was not provided and will be requested during follow up.
After the first dose I had bruising at the injection site for a week; a half with minor soreness; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for self). A 27-years-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation; Solution for Injection, Batch/Lot Number: gn6206 and Expiry date was not provided), dose 1 via an unspecified route of administration, administered in arm left on 04Mar2021 17:30 as dose 1, single for COVID-19 immunisation. Medical history included mood disorder, Asthma, Migraines, Arthritis, Attention deficit hyperactivity disorder (ADD), Known allergies to mosquitos, fire ants, sun from an unknown date and unknown if ongoing. Patient was not pregnant at time of vaccination. Concomitant medications included Amfetamine Aspartate, Amfetamine Sulfate, Dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); Fluticasone Furoate, Vilanterol trifenatate (BREO ELLIPTA); Lithium; Topiramate and Verapamil taken for an unspecified indication, start and stop date were not reported. The patient experienced drug hypersensitivity with Lamictal, Neosporine, Imitrex on unspecified date(s). The patient did not have covid prior vaccination, Patient did not test covid post vaccination. There were no other vaccine in four weeks. The patient experienced after the first dose patient had bruising at the injection site for a week and a half with minor soreness on an unspecified date. The outcome of events was unknown. No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a pharmacy intern refers to a patient of unknown age and gender. No pertinent medical history was reported. On an unknown date, the patient was vaccinated with first dose of ZOSTAVAX (dose, route, lot# and expiration date were not reported). On 01-SEP-2015, the patient was vaccinated with second dose of ZOSTAVAX (lot # K019388 and expiration date 20-JAN-2016) (dose and route were not reported). The two doses of ZOSTAVAX were administered to a patient, less than one year from one another. No adverse reactions were reported. No Product Quality Complaint (PQ) was involved. Additional information has been requested.
This is a spontaneous report from a contactable medical assistant on behalf of a doctor via a Company representative and from the contactable physician. This medical assistant reported similar events for 3 patients. This is the third of 3 reports. A 20-year-old female patient of an unspecified ethnicity received TRUMENBA; (lot M74081, expiry date 30Jun2017) on 15Jul2016 at 0.5 ml single intramuscular in the deltoid for immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2016 the patient experienced pain at injection site that traveled down the arm, fibroid type of swelling and limitation of arm movement. Therapeutic measures were taken as a result of the events, the patient was given antibiotics prophylactically (it was unknown if she was still taking them). The events did not require hospitalization. The patient recovered from the reported events on an unspecified date in 2016. The reporting physician considered the suspect vaccine has a causal effect to the adverse events. Follow up (26Sep2016): New information from a contactable physician includes: patient age, suspect vaccine details, reporter causality assessment. Follow-up attempts completed. No further information expected. Sender's Comments: Linked Report(s): US-PFIZER INC-2016376082 same reporter, same drug, same events, different patient;US-PFIZER INC-2016376280 same reporter, same drug, same events, different patient.
Patient experience syncope about 10 minutes after the shot - nausea, clammy hands, stomach pains, dizziness
Arm has red area that is swollen and itched.   Symptoms did not appear until 8 days later.  Itching only lasted a short while. The redness and swelling is still present at the time she reported it to me.
On 22 Feb 03 developed "spots before her right eye", no pain , no D/C, no erythema. Seen by opthalmology and given diagnosis of of uveitis of unknown etiology.  Various labs and x-rays pending. Currently taking steroid eye gtts with slight improvement. Denies joint pain, might sweats, oral ulcers, alopecia. Reports rash on left cheek x 4 ds which resolved with HC cream. Also c/o tingling in feet / fingers that lasts a few seconds daily sometimes more than 1x/day. Usually occurs when sitting down.  FMH: 1. Identical twin being worked up currently for multiple sclerosis. 2. Paternal aunt has lupus
Very tired; Unable to lift her arm due to pain; the pain in her arm got worse; Feeling very very hot; Unable to lift her arm due to pain; Fever/ 102.7 fever after taking Tylenol; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Unable to lift her arm due to pain), PAIN IN EXTREMITY (Unable to lift her arm due to pain), CONDITION AGGRAVATED (the pain in her arm got worse), FEELING HOT (Feeling very very hot) and FATIGUE (Very tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced PYREXIA (Fever/ 102.7 fever after taking Tylenol). On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MOBILITY DECREASED (Unable to lift her arm due to pain). On 27-Mar-2021, the patient experienced PAIN IN EXTREMITY (Unable to lift her arm due to pain), CONDITION AGGRAVATED (the pain in her arm got worse) and FEELING HOT (Feeling very very hot). On 28-Mar-2021, the patient experienced FATIGUE (Very tired). At the time of the report, MOBILITY DECREASED (Unable to lift her arm due to pain) had resolved and PAIN IN EXTREMITY (Unable to lift her arm due to pain), CONDITION AGGRAVATED (the pain in her arm got worse), FEELING HOT (Feeling very very hot), FATIGUE (Very tired) and PYREXIA (Fever/ 102.7 fever after taking Tylenol) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Temperature perception test increased: 102.7 temperature.         This case was linked to US-MODERNATX, INC.-MOD-2021-062383, US-MODERNATX, INC.-MOD-2021-062383 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-062383:Cross linked with Husband case US-MODERNATX, INC.-MOD-2021-062383:wife case
Pt started having redness and warmth at injection site the morning after injection given, developed rapidly. seen in MD office 28 hours later -dx large local reaction. continued to worsen and went to ED 34 hours after. noticed some blistering/fluid filled lesions. redness spreading. no fever. dx with cellulitis and put on clindamycin. seen back in our office the next day after 2 days of clindamycin. continued to have increasing redness/induration. no fever still. dx with arthur reaction
12 hrs after shot: fever of 101+, aches, chills, nausea, sore arm at injection site Second day after shot: redness in circle around site, swollen at site, sore under left armpit
AT 10:50 AM (5 MINUTES POST VACCINATION), FELT LIKE 'HEAD IS FILLING UP, MY LIPS ARE PUFFY, AND I HAVE NUMBNESS UNDER MY EYES AND NOSE'. RECEIVED BENADRYL 12.5MG AT 10:59AM. CONDITION RESOLVED BY 11:15AM. MD WAS NOTIFIED.